The impact of memantine and cholinesterase inhibitor initiation for Alzheimer disease on the use of antipsychotic agents: analysis using the Régie de l'Assurance Maladie du Québec database.
about
Antipsychotic prescribing for Alzheimer's disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study.Memantine for treatment of moderate or severe Alzheimer's disease patients in urban China: clinical and economic outcomes from a health economic model.
P2860
The impact of memantine and cholinesterase inhibitor initiation for Alzheimer disease on the use of antipsychotic agents: analysis using the Régie de l'Assurance Maladie du Québec database.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The impact of memantine and ch ...... ce Maladie du Québec database.
@en
The impact of memantine and ch ...... ce Maladie du Québec database.
@nl
type
label
The impact of memantine and ch ...... ce Maladie du Québec database.
@en
The impact of memantine and ch ...... ce Maladie du Québec database.
@nl
prefLabel
The impact of memantine and ch ...... ce Maladie du Québec database.
@en
The impact of memantine and ch ...... ce Maladie du Québec database.
@nl
P2093
P2860
P1476
The impact of memantine and ch ...... ce Maladie du Québec database.
@en
P2093
Anne Crochard
Catherine Beauchemin
Jean Lachaine
Sébastien Bineau
P2860
P304
P356
10.1177/070674371305800404
P407
P577
2013-04-01T00:00:00Z